2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
|Articles|December 2, 2002
- Pharmaceutical Technology-12-02-2002
- Volume 26
- Issue 12
Fifth Annual International Employment Survey
Author(s)Maribel Rios
More than 1600 industry employees report about the status of their current work environment, including salary, job environment, and outlook for next year.
Advertisement
Articles in this issue
almost 24 years ago
Generic Drugs Take Center Stagealmost 24 years ago
Contract Servicesalmost 24 years ago
Determination by Analytical Sieving: Particle-Size Distribution, Part IIIAdvertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Inluriyo-Verzenio Combo Doubles PFS, Adds Oral Complexity
2
Can AI Agents Satisfy CGMP Documentation Requirements?
3
PharmTech Weekly Roundup—September 18, 2026
4
Introducing the "PharmTech AI Pulse Check" Expert Video Series
5